Kenya COPD Market Analysis

$3,000.00$7,500.00

  • Type: Common Disease Area
  • Published : June 2021
  • Region: Africa
  • Country: Kenya
  • Report ID : 4847

  • Format: PPT, PDF

Kenya Chronic Obstructive Pulmonary Disease (COPD) Drug Market: Segmented by Drug Class (Phosphodiestrase-4 inhibitors, Long-acting Bronchodilators, Short-acting Bronchodilators, Methylxanthines and Corticosteroids), Route of Administration (Oral drugs, Inhalation drugs and Parenteral route) and Distribution Channel (Hospital Pharmacies, Retail Pharmacies and Online Pharmacies)- Growth, Trends, And Forecasts (2019 – 2028)

Clear
SKU: 4847 Categories: ,

Report Overview

The Chronic Obstructive Pulmonary Disease (COPD) drug market size in Kenya stood at USD xx billion in 2019 and is projected to reach USD xx billion by 2028, exhibiting a CAGR of xx% during the forecast period

Chronic Obstructive Pulmonary Disease (COPD) is a preventable and treatable disease characterized by airflow limitation that is progressive and associated to an abnormal response of the lungs to noxious particles or gases. Smoking is the main risk factor of COPD. Exposure to occupational or domestic fumes, or previous infection can also cause the disease. In Kenya, COPD is estimated to cause the same amount of DALYs as ischemic heart disease, stroke and epilepsy indicating that it is grossly underdiagnosed and treated.  There is a high prevalence of COPD among women due to the exposure to fumes from wood and charcoal used in cooking.

Market Drivers

The market is majorly driven by the rising prevalence of COPD in Kenya. Chronic Obstructive Pulmonary Disease (COPD) causes substantial burden of disease in low- and middle-income countries, but there are limited data from Africa. A Meta analysis of five spirometry-based studies from Africa reported a mean prevalence of COPD as 13.4%, ranging from 9.4 to 22.1%.

Smoking is the main risk factor for development of Chronic Obstructive Pulmonary Disease. According to WHO, about 86.1% of Kenyan adults are exposed to tobacco smoke in bars and night clubs and 24.8% of youth being exposed at home.

In Kenya, 7.2% of school-going adolescents smoke cigarettes, while 8.5% use other forms of tobacco products. Dyspnoea is the main reason for COPD having the 10th highest morbidity in low- and middle- income countries. Mortality increases with decreasing lung function, infective exacerbations and acute respiratory failure.

High levels of tuberculosis infection in Kenya also increases COPD prevalence.

1. Kenya COPD Drug Market Overview………………………….………………………..
A. Market Size
2. Market Growth Drivers…………………………………………………………………
A. Rise in Prevalence of Chronic Obstructive Pulmonary Disease (COPD) in Kenya
B. Increase in the Risk Factors Associated with the Disease
3. Major Chronic Obstructive Pulmonary Disease (COPD) Types………………
A. Chronic Bronchitis
B. Emphysema
4. COPD Drug Market Segmentation……………………………………………………
A. Drug Class
I. Phosphodiestrase-4 Inhibitors
II. Long-Acting Bronchodilators
III. Short-Acting Bronchodilators
IV. Methylxanthines
V. Corticosteroids
VI. Others
B. Route of Administration
I. Oral
II. Inhalation Drugs
C. Distribution Channel
I. Hospital Pharmacies
II. Retail Pharmacies
III. Online Pharmacies
5. COPD Major Drugs Market Share……………………………………………………
A. Market Analysis, Insights and Forecast – By Revenue
6. Competitive Landscape………………………………………………..………………
A. Major Players
B. Products in Pipeline
7. Key Company Profiles……………………………………………………………..…..
A. AstraZeneca Company overview, Product & Services, Strategies & Financials
B. Cipla Company overview, Product & Services, Strategies & Financials
C. GlaxoSmithKline (GSK) Company, Product & Services, Strategies & Financials
8. Healthcare Policies and Regulatory Landscape………………………………….
A. Policy changes and Reimbursement scenario
9. Factors Driving Future Growth……………………………………………………….
A. New Trends and Development of Chronic Obstructive Pulmonary Disease (COPD) drug market
B. Future Opportunities
10. Conclusion

Market Segmentation

By Drug Class:

On the basis of drug class, the chronic obstructive pulmonary disease (COPD) drug market is segmented into phosphodiestrase-4 inhibitors, long-acting bronchodilators, short-acting bronchodilators, methylxanthines and corticosteroids.

The rapid and short acting beta 2 agonists include salbutamol, fenoterol, terbutaline, pirbuterol and procaterol. Salmetrol and Formoterol are long-acting beta 2 agonists with prolonged bronchodilator action that lasts up to 12 hours.

 By Route of Administration:

On the basis of route of administration, the asthma drug market can be segmented into oral drugs, inhalation drugs and parenteral route.

The inhaler segment includes dry powder, metered dose, and soft mist inhalers. The metered-dose inhalers (MDIs) segment dominates the market. This is majorly attributed to reliability, versatility, self-containment, easy availability, portability, and cost-efficient medical aerosol delivery option among others.

 By Distribution Channel:

On the basis of distribution channel, the market for cardiovascular drugs can be segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others. The hospital segment is expected to dominate the market throughout the forecast period

 Major Players

Top drug makers are making sizeable investments in clinical trials focused on reducing Chronic Obstructive Pulmonary Disease exacerbations, in a move to develop advanced and more efficacious drugs for managing COPD. Players holding prominent position in the COPD drug market include Abbott Laboratories, F. Hoffmann-La Roche, Merck & Co., AstraZeneca, Cipla, GlaxoSmithKline, and Novartis AG.

Cipla is leading the respiratory therapeutics market in Kenya with its robust pipeline drugs like Duolin, Asthalin, Aerocort and Budecort.

Research Methodology

Insights10 will provide you reports within 10 key parameters which are:

  1. Market overview
  2. Market growth drivers & restraints
  3. Epidemiology or disease type
  4. Market segmentation
  5. Market share
  6. Competitive landscape
  7. Key company profiles
  8. Healthcare policies & regulatory framework
  9. Reimbursement scenario
  10. Factors driving future growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision making for business stakeholders. Our focused approach to develop reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

Our analysis methodology involves three critical stages:

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers and researchers across countries through which we engage with local experts to gather key data points and assumptions around each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain the high level of accuracy and consistency. The market data is analysed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, market share as well as segment-level analysis of the specific market. Our report includes precise, to the point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

  • Statistical Databases
  • Company Websites/Annual Reports
  • Trade Publications
  • Online Databases
  • Published Research Reports
  • Whitepapers
  • Press Releases of Key Market Players

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameter and micro indicators. The macro parameters includes changes in government policies, demand and supply of the market, government intervention programs and major market share. The micro indicators GDP growth, market size, market volume etc. We also understand nuances specific to each country like US, Canada, India, Germany, etc. and have worked across 60+ countries and hence no only understand global trends, but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. start with large overall market and segment different areas and bottom-up approach i.e. start with population and epidemiology and roll up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach mainly used for new product forecasting and bottom-up approach is used for demand estimation of any product for different countries summed up to form total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and Africa for the period of 2020 to 2028. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape and policy and regulatory scenario and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases and the company level averages etc.

We make sure to finalize the numbers in alignment to the market research. Firstly, our internal experts ensure thorough validation and checking to ensure the accurate and precise analysis and then validation is also done using multiple data analysis model.  Two level validation is done and entails finalization of report scope and to way of representation pattern.

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analysed and synthesized. A second series of interviews are done if necessary to check and validate. The future opportunities are analysed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results are then, interpreted by considering following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue / volume
  • Analyzing current needs and determining penetration to estimate market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and its impact to the different segments within the market.
Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumptions.
The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy this report, please complete the form below.

    We value your inquiry and offer free customization with every report to fulfil your exact research needs.

    This website is secure and your personal details are safe.



    This report addresses

    • Market intelligence to enable effective decision making
    • Growth opportunities and trend analysis
    • Competitive benchmarking
    • Historical data & forecasts
    • Regional opportunities

    Need more?

    • Speak to our analyst to know how this research was put together
    • Add more countries or regions as part of customisation
    • Understand how this report can have direct impact on your revenue

    Get a custom report based on your requirements